Stocklytics Platform
Asset logo for symbol AIM
AIM ImmunoTech
AIM53
$0.19arrow_drop_up0.31%$0.00
Penny Stock
Asset logo for symbol AIM
AIM53

$0.19

arrow_drop_up0.31%

Performance History

Chart placeholder
Key Stats
Open$0.18
Prev. Close$0.18
EPS-0.47
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$12.43M
PE Ratio-
LOWHIGH
Day Range0.18
0.20
52 Week Range0.16
0.62
Ratios
Revenue-
EBITDA Margin %-
EPS-0.47

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About AIM ImmunoTech (AIM)

AIM ImmunoTech Inc (AIM) is a biopharmaceutical company that specializes in the research and development of immunological agents to treat various diseases. The company's stock price history has seen its fair share of ups and downs over the years. It has experienced both significant gains and losses, reflecting the volatility of the biotech industry. Investors should carefully analyze the stock's performance and consider the potential risks before making any investment decisions.
AIM ImmunoTech Inc (AIM) is constantly making headlines with its latest developments and news. Investors and analysts eagerly await updates on the company's research progress, clinical trials, and regulatory approvals. These updates can significantly impact the stock's performance and attract market attention. Therefore, it is crucial to stay informed about the latest AIM ImmunoTech Inc news, as it can provide valuable insights into the company's future prospects.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Thomas K. Equels Esq., J.D., M.S.
Headquarters
Ocala
Employees
22
Exchange
NYSE
add AIM ImmunoTech  to watchlist

Keep an eye on AIM ImmunoTech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is AIM ImmunoTech 's (AIM) price per share?

The current price per share for AIM ImmunoTech (AIM) is $0.2. The stock has seen a price change of $0 recently, indicating a 0.32% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for AIM ImmunoTech (AIM)?

For AIM ImmunoTech (AIM), the 52-week high is $0.62, which is 217.95% from the current price. The 52-week low is $0.16, the current price is 18.9% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is AIM ImmunoTech (AIM) a growth stock?

AIM ImmunoTech (AIM) has shown an average price growth of -5.34% over the past three years. It has received a score of 12 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying AIM ImmunoTech as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is AIM ImmunoTech (AIM) stock price performance year to date (YTD)?

As of the latest data, AIM ImmunoTech (AIM) has a year-to-date price change of -58.95%. Over the past month, the stock has experienced a price change of -8.45%. Over the last three months, the change has been -22.83%. Over the past six months, the figure is -50.13%. Looking at a longer horizon, the five-year price change stands at -57.94%.
help

Is AIM ImmunoTech (AIM) a profitable company?

AIM ImmunoTech (AIM) has a net income of -$28.96M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 79.21% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.39K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 43.26%, providing insight into the company's sales performance and growth. The gross profit is $160K. Operating income is noted at -$31.92M. Furthermore, the EBITDA is -$31.36M.
help

What is the market capitalization of AIM ImmunoTech (AIM)?

AIM ImmunoTech (AIM) has a market capitalization of $12.44M. The average daily trading volume is 0.19, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level